Kalaris Therapeutics, Inc. (KLRS) — Defensive Interval Ratio
Kalaris Therapeutics, Inc. (KLRS) has a Defensive Interval Ratio of 749 days as of December 2025. Defensive assets of $19.93 Million (cash $-, short-term investments $19.93 Million, receivables $-) cover 749 days of daily cash needs of $26.61K/day. Check KLRS goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Kalaris Therapeutics, Inc. Defensive Interval Ratio (2018–2025)
This chart shows how Kalaris Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 6 annual periods from 2018 to 2025. As of December 2025, the ratio stands at 749 days, meaning defensive assets of $19.93 Million can fund 749 days of operations without new revenue. Also explore Kalaris Therapeutics, Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Kalaris Therapeutics, Inc. (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for Kalaris Therapeutics, Inc. from 2018 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is Kalaris Therapeutics, Inc. worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 749 days | $19.93 Million | $26.61K/day | $- | $19.93 Million | ▲ +749 days |
| 2024 | 0 days | $0.00 | $14.35K/day | $- | $0.00 | ▼ -448 days |
| 2021 | 448 days | $46.51 Million | $103.71K/day | $- | $46.46 Million | ▼ -6502 days |
| 2020 | 6951 days | $234.11 Million | $33.68K/day | $- | $233.66 Million | ▲ +4323 days |
| 2019 | 2628 days | $65.55 Million | $24.95K/day | $- | $64.99 Million | ▲ +2598 days |
| 2018 | 29 days | $302.00K | $10.24K/day | $- | $- | — |